A detailed history of Harvest Fund Management Co., LTD transactions in Dexcom Inc stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 18,459 shares of DXCM stock, worth $1.48 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
18,459
Previous 12,034 53.39%
Holding current value
$1.48 Million
Previous $1.36 Million 9.31%
% of portfolio
0.07%
Previous 0.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $411,200 - $745,685
6,425 Added 53.39%
18,459 $1.24 Million
Q2 2024

Aug 08, 2024

SELL
$110.31 - $140.45 $345,049 - $439,327
-3,128 Reduced 20.63%
12,034 $1.36 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $1.34 Million - $1.65 Million
11,767 Added 346.6%
15,162 $2.1 Million
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $25,893 - $42,586
343 Added 11.24%
3,395 $421,000
Q3 2023

Nov 06, 2023

SELL
$86.06 - $137.93 $261,794 - $419,583
-3,042 Reduced 49.92%
3,052 $285,000
Q2 2023

Jul 07, 2023

BUY
$112.47 - $130.98 $89,188 - $103,867
793 Added 14.96%
6,094 $783,000
Q1 2023

May 10, 2023

BUY
$104.0 - $122.92 $223,184 - $263,786
2,146 Added 68.02%
5,301 $616,000
Q4 2022

Feb 06, 2023

BUY
$84.98 - $122.67 $252,390 - $364,329
2,970 Added 1605.41%
3,155 $333,000
Q3 2022

Nov 10, 2022

BUY
$76.35 - $94.18 $5,878 - $7,251
77 Added 71.3%
185 $15,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $5,507 - $10,764
81 Added 300.0%
108 $8,000
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $117,505 - $162,619
-1,249 Reduced 97.88%
27 $13,000
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $93,636 - $117,393
721 Added 129.91%
1,276 $690,000
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $59,224 - $79,464
555 New
555 $303,000
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $16,873 - $20,843
-199 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $64,038 - $85,794
-821 Reduced 80.49%
199 $73,000
Q3 2020

Nov 04, 2020

BUY
$95.51 - $112.95 $22,253 - $26,317
233 Added 29.61%
1,020 $390,000
Q2 2020

Aug 12, 2020

BUY
$62.68 - $105.34 $3,259 - $5,477
52 Added 7.07%
787 $314,000
Q1 2020

May 08, 2020

BUY
$47.79 - $75.63 $14,289 - $22,613
299 Added 68.58%
735 $197,000
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $8,129 - $12,718
222 Added 103.74%
436 $146,000
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $7,603 - $9,373
214 New
214 $32,000
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $8,129 - $11,364
-292 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$28.07 - $38.18 $61,697 - $83,919
-2,198 Reduced 88.27%
292 $35,000
Q4 2018

Feb 13, 2019

SELL
$26.99 - $37.37 $3,913 - $5,418
-145 Reduced 5.5%
2,490 $298,000
Q3 2018

Oct 31, 2018

BUY
$23.35 - $36.72 $54,335 - $85,447
2,327 Added 755.52%
2,635 $377,000
Q2 2018

Aug 03, 2018

BUY
$17.54 - $25.22 $5,402 - $7,767
308 New
308 $29,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.